Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial

Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial

Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D). How GLP-1RAs modulate diabetic atherosclerosis remains to be determined yet. M...

Full description

Bibliographic Details
Main Authors: Yu Kataoka, Satoshi Kitahara, Sayaka Funabashi, Hisashi Makino, Masaki Matsubara, Miki Matsuo, Yoko Omura-Ohata, Ryo Koezuka, Mayu Tochiya, Tamiko Tamanaha, Tsutomu Tomita, Kyoko Honda-Kohmo, Michio Noguchi, Kota Murai, Kenichiro Sawada, Takamasa Iwai, Hideo Matama, Satoshi Honda, Masashi Fujino, Kazuhiro Nakao, Shuichi Yoneda, Kensuke Takagi, Fumiyuki Otsuka, Yasuhide Asaumi, Kiminori Hosoda, Stephen J. Nicholls, Satoshi Yasuda, Teruo Noguchi
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Atherosclerosis Plus
Subjects:
Glucagon-like peptide-1 analogues
Lipidic plaque
Coronary atherosclerosis
Type 2 diabetes mellitus
Intravascular ultrasound
Near-infrared spectroscopy
Online Access:http://www.sciencedirect.com/science/article/pii/S2667089524000099

Internet

http://www.sciencedirect.com/science/article/pii/S2667089524000099

Similar Items